IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (10)
Barclays
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 | SiTime Corporat | Capital-Goods | 13 | 4 | BRCL | Stifel | 24% | 43.5% | |||
Nov 7 | Silvergate Capi | Finance | 12 | 3 | BRCL | KBW | 27.7% | 4.3% | |||
Sep 26 | Oportun Financi | Finance | 15 | 6 | BRCL | JPM | JEFF | 27.2% | 7.8% | ||
Aug 8 | InMode Ltd. | Health-Care | 14 | 5 | BRCL | UBS | CNCD | 71% | -3.1% | ||
Aug 1 | Sundial Growers | Health-Care | 13 | 11 | COWN | BMO | BRCL | 84.7% | -34.8% | ||
Jun 27 | Change Healthca | NA | 13 | 42 | BRCL | GS | JPM | 42.6% | 15.4% | ||
Apr 17 | Palomar Holding | NA | 15 | 5 | BRCL | JPM | KBW | 77.3% | 26.6% | ||
Mar 28 | Precision BioSc | NA | 16 | 7 | BRCL | GS | JPM | 48.9% | 9% | ||
Feb 8 | Gossamer Bio In | NA | 16 | 17 | BAML | LRNK | BRCL | 34.2% | 12.1% | ||
Jan 31 | New Fortress En | NA | 14 | 20 | MS | BRCL | CITI | 20.2% | -6.6% |
*
Lead manager or one of top three managers in an underwriting team.